Cargando…
Discovering Anti-platelet Drug Combinations with an Integrated Model of Activator-Inhibitor Relationships, Activator-Activator Synergies and Inhibitor-Inhibitor Synergies
Identifying effective therapeutic drug combinations that modulate complex signaling pathways in platelets is central to the advancement of effective anti-thrombotic therapies. However, there is no systems model of the platelet that predicts responses to different inhibitor combinations. We developed...
Autores principales: | Lombardi, Federica, Golla, Kalyan, Fitzpatrick, Darren J., Casey, Fergal P., Moran, Niamh, Shields, Denis C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405222/ https://www.ncbi.nlm.nih.gov/pubmed/25875950 http://dx.doi.org/10.1371/journal.pcbi.1004119 |
Ejemplares similares
-
Peptides derived from cadherin juxtamembrane region inhibit platelet function
por: Golla, Kalyan, et al.
Publicado: (2018) -
The Prospective Synergy of Antitubercular Drugs With NAD Biosynthesis Inhibitors
por: Rohde, Kyle H., et al.
Publicado: (2021) -
Treatment of Brain Metastases: The Synergy of Radiotherapy and Immune Checkpoint Inhibitors
por: Matsui, Jennifer K., et al.
Publicado: (2022) -
Discovering Pair-wise Synergies in Microarray Data
por: Chen, Yuan, et al.
Publicado: (2016) -
Synergy between Proteasome Inhibitors and Imatinib Mesylate in Chronic Myeloid Leukemia
por: Hu, Zheng, et al.
Publicado: (2009)